HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis

The widespread use of the integrase strand transfer inhibitor (INSTI) dolutegravir in first-line and second-line antiretroviral therapy (ART) might facilitate emerging resistance. The DTG RESIST study combined data from HIV cohorts to examine patterns of drug resistance mutations (DRMs) and identify...

Full description

Bibliographic Details

Published in:	The lancet HIV Vol. 10; no. 11; p. e733
Main Authors:	Loosli, Tom, Hossmann, Stefanie, Ingle, Suzanne M, Okhai, Hajra, Kusejko, Katharina, Mouton, Johannes, Bellecave, Pantxika, van Sighem, Ard, Stecher, Melanie, d'Arminio Monforte, Antonella, Gill, M John, Sabin, Caroline A, Maartens, Gary, Günthard, Huldrych F, Sterne, Jonathan A C, Lessells, Richard, Egger, Matthias, Kouyos, Roger D
Format:	Journal Article
Language:	English
Published:	Netherlands 01.11.2023
Subjects:	Cohort Studies Drug Resistance, Viral - genetics Heterocyclic Compounds, 3-Ring - pharmacology Heterocyclic Compounds, 3-Ring - therapeutic use HIV Infections - drug therapy HIV Integrase Inhibitors - pharmacology HIV Integrase Inhibitors - therapeutic use HIV Seropositivity - drug therapy HIV-1 - genetics Humans Lamivudine - therapeutic use Reverse Transcriptase Inhibitors - therapeutic use
ISSN:	2352-3018, 2352-3018
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!